Literature DB >> 22553238

Sequetyping: serotyping Streptococcus pneumoniae by a single PCR sequencing strategy.

Marcus H Leung1, Kevin Bryson, Kathrin Freystatter, Bruno Pichon, Giles Edwards, Bambos M Charalambous, Stephen H Gillespie.   

Abstract

The introduction of pneumococcal conjugate vaccines necessitates continued monitoring of circulating strains to assess vaccine efficacy and replacement serotypes. Conventional serological methods are costly, labor-intensive, and prone to misidentification, while current DNA-based methods have limited serotype coverage requiring multiple PCR primers. In this study, a computer algorithm was developed to interrogate the capsulation locus (cps) of vaccine serotypes to locate primer pairs in conserved regions that border variable regions and could differentiate between serotypes. In silico analysis of cps from 92 serotypes indicated that a primer pair spanning the regulatory gene cpsB could putatively amplify 84 serotypes and differentiate 46. This primer set was specific to Streptococcus pneumoniae, with no amplification observed for other species, including S. mitis, S. oralis, and S. pseudopneumoniae. One hundred thirty-eight pneumococcal strains covering 48 serotypes were tested. Of 23 vaccine serotypes included in the study, most (19/22, 86%) were identified correctly at least to the serogroup level, including all of the 13-valent conjugate vaccine and other replacement serotypes. Reproducibility was demonstrated by the correct sequetyping of different strains of a serotype. This novel sequence-based method employing a single PCR primer pair is cost-effective and simple. Furthermore, it has the potential to identify new serotypes that may evolve in the future.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22553238      PMCID: PMC3405617          DOI: 10.1128/JCM.06384-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  66 in total

1.  A new pneumococcal serotype, 11E, has a variably inactivated wcjE gene.

Authors:  Juan J Calix; Moon H Nahm
Journal:  J Infect Dis       Date:  2010-07-01       Impact factor: 5.226

2.  Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete.

Authors:  William P Hanage; Jonathan A Finkelstein; Susan S Huang; Stephen I Pelton; Abbie E Stevenson; Ken Kleinman; Virginia L Hinrichsen; Christophe Fraser
Journal:  Epidemics       Date:  2010-06       Impact factor: 4.396

Review 3.  Continued control of pneumococcal disease in the UK - the impact of vaccination.

Authors:  R A Gladstone; J M Jefferies; S N Faust; S C Clarke
Journal:  J Med Microbiol       Date:  2010-10-21       Impact factor: 2.472

4.  Improved detection of nasopharyngeal cocolonization by multiple pneumococcal serotypes by use of latex agglutination or molecular serotyping by microarray.

Authors:  Paul Turner; Jason Hinds; Claudia Turner; Auscharee Jankhot; Katherine Gould; Stephen D Bentley; François Nosten; David Goldblatt
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

5.  Antibiotic resistance in invasive Streptococcus pneumoniae isolates identified in Scotland between 1999 and 2007.

Authors:  Benjamin Cooke; Andrew Smith; Mathew Diggle; Karen Lamb; Christopher Robertson; Donald Inverarity; Johanna Jefferies; Giles Edwards; Timothy Mitchell; Stuart Clarke; Jim McMenamin
Journal:  J Med Microbiol       Date:  2010-07-22       Impact factor: 2.472

6.  Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use.

Authors:  Sandra I Aguiar; Maria J Brito; José Gonçalo-Marques; José Melo-Cristino; Mário Ramirez
Journal:  Vaccine       Date:  2010-06-15       Impact factor: 3.641

7.  Molecular analysis of Streptococcus pneumoniae clones causing invasive disease in children in Singapore.

Authors:  J M C Jefferies; W S N Tee; S C Clarke
Journal:  J Med Microbiol       Date:  2011-02-17       Impact factor: 2.472

8.  Multiple colonization with S. pneumoniae before and after introduction of the seven-valent conjugated pneumococcal polysaccharide vaccine.

Authors:  Silvio D Brugger; Pascal Frey; Suzanne Aebi; Jason Hinds; Kathrin Mühlemann
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

9.  Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.

Authors:  Rosalyn J Singleton; Thomas W Hennessy; Lisa R Bulkow; Laura L Hammitt; Tammy Zulz; Debby A Hurlburt; Jay C Butler; Karen Rudolph; Alan Parkinson
Journal:  JAMA       Date:  2007-04-25       Impact factor: 56.272

10.  Pneumococcal serotypes in children in 4 European countries.

Authors:  Germaine Hanquet; Esther Kissling; Asuncion Fenoll; Robert George; Agnes Lepoutre; Tinne Lernout; David Tarragó; Emmanuelle Varon; Jan Verhaegen
Journal:  Emerg Infect Dis       Date:  2010-09       Impact factor: 6.883

View more
  30 in total

1.  Pan-PCR, a computational method for designing bacterium-typing assays based on whole-genome sequence data.

Authors:  Joy Y Yang; Shelise Brooks; Jennifer A Meyer; Robert R Blakesley; Adrian M Zelazny; Julia A Segre; Evan S Snitkin
Journal:  J Clin Microbiol       Date:  2012-12-19       Impact factor: 5.948

2.  Direct detection and prediction of all pneumococcal serogroups by target enrichment-based next-generation sequencing.

Authors:  Margaret Ip; Veranja Liyanapathirana; Irene Ang; Kitty S C Fung; T K Ng; Haokui Zhou; Dominic N C Tsang
Journal:  J Clin Microbiol       Date:  2014-10-01       Impact factor: 5.948

3.  Application of capsular sequence typing (CST) to serotype non-viable Streptococcus pneumoniae isolates from an old collection.

Authors:  G Errico; C Lucarelli; F D'Ambrosio; M Del Grosso; L Ingrosso; A Pantosti; R Camilli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-31       Impact factor: 3.267

4.  Decreased ceftriaxone susceptibility in emerging (35B and 6C) and persisting (19A) Streptococcus pneumoniae serotypes in the United States, 2011-2012: ceftaroline remains active in vitro among β-lactam agents.

Authors:  Rodrigo E Mendes; Donald Biek; Ian A Critchley; David J Farrell; Helio S Sader; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

Review 5.  Influence of bacterial interactions on pneumococcal colonization of the nasopharynx.

Authors:  Joshua R Shak; Jorge E Vidal; Keith P Klugman
Journal:  Trends Microbiol       Date:  2012-12-25       Impact factor: 17.079

6.  Distribution of serotypes and antibiotic susceptibility patterns among invasive pneumococcal diseases in Saudi Arabia.

Authors:  Yazeed A Al-Sheikh; Yazeed A Al-Sherikh; Lakshmana K Gowda; M Marie Mohammed Ali; James John; Dabwan Khaled Homoud Mohammed; Pradeep Chikkabidare Shashidhar
Journal:  Ann Lab Med       Date:  2014-04-08       Impact factor: 3.464

7.  Noninvasive Streptococcus pneumoniae serotypes recovered from hospitalized adult patients in the United States in 2009 to 2012.

Authors:  Rodrigo E Mendes; Rosalind C Hollingsworth; Andrew Costello; Ronald N Jones; Raul E Isturiz; Dial Hewlett; David J Farrell
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

Review 8.  Pneumococcal Capsules and Their Types: Past, Present, and Future.

Authors:  K Aaron Geno; Gwendolyn L Gilbert; Joon Young Song; Ian C Skovsted; Keith P Klugman; Christopher Jones; Helle B Konradsen; Moon H Nahm
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

9.  Antimicrobial activity of solithromycin against serotyped macrolide-resistant Streptococcus pneumoniae isolates collected from U.S. medical centers in 2012.

Authors:  D J Farrell; R E Mendes; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  2015-01-20       Impact factor: 5.191

10.  Comparative Clinical Evaluation of NeoPlex RB-8 with Seeplex PneumoBacter ACE for Simultaneous Detection of Eight Respiratory Bacterial Pathogens.

Authors:  Jeong Woo Kim; Seong Soo Hong; In Seop Lee; Hyun Young Chi; Soo-Ok Kim; Hyeong Nyeon Kim; Sun Pyo Hong
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.